학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 2건 | 목록 1~20
Academic Journal
Peremiquel-Trillas P; Cancer Epidemiology Research Programme, Cancer Epidemiology and Prevention Department, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Epidemiology and Public Health Programme, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.; CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.; School of Medicine and Clinical Sciences, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.; Saura-Lázaro A; Cancer Epidemiology Research Programme, Cancer Epidemiology and Prevention Department, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Epidemiology and Public Health Programme, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.; Benavente-Moreno Y; Cancer Epidemiology Research Programme, Cancer Epidemiology and Prevention Department, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Epidemiology and Public Health Programme, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.; CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Casabonne D; Cancer Epidemiology Research Programme, Cancer Epidemiology and Prevention Department, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Epidemiology and Public Health Programme, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.; CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Loureiro E; Computer Science Services, Technology & Physics, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Computational Science and Artificial Intelligence, Schoolof Computer Science of Coruña, University of Coruña (UDC), Coruña, Spain.; Cabrera S; Research Nursing Department, Institut Català d'Oncologia (ICO), Badalona, Spain.; Duran A; Nursing Department, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Garrote L; Nursing Department, Institut Català d'Oncologia, Badalona, Spain.; Brao I; Nursing Department, Institut Català d'Oncologia (ICO), Girona, Spain.; Trelis J; School of Medicine and Clinical Sciences, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.; Palliative Care Department and Medical Director, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Galán M; Esofagogastric Tumours Functional Unit and Medical Director, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Soler F; Pharmacy Service and Medical Director, Institut Català d'Oncologia (ICO), Girona, Spain.; Julià J; Palliative Care Department and Medical Director, Institut Català d'Oncologia (ICO), Badalona, Spain.; School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.; Cortasa D; Medical Director, Institut català d'Oncologia, Tarragona, Spain.; Domínguez MÁ; Microbiology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Infectious Diseases Programme, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.; Department of Pathology Experimental Therapeutics, Universitat de Barcelona, L'Hosìtalet de Llobregat, Spain.; Albasanz-Puig A; Infectious Disease Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Infectious Disease Unit, Institut català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; CIBER of Infectious Diseases (CIBERINFEC), Madrid, Spain.; Gudiol C; Infectious Disease Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Infectious Disease Unit, Institut català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; CIBER of Infectious Diseases (CIBERINFEC), Madrid, Spain.; Ramírez-Tarruella D; Preventive Medicine Unit, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Muniesa J; Computer Science Services, Technology & Physics, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Rivas JP; Computer Science Services, Technology & Physics, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Muñoz-Montplet C; Computer Science Services, Technology & Physics, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Medical Physics and Radiation Protection Department, Institut Català d'Oncologia (ICO), Girona, Spain.; Department of Medical Sciences, Universitat de Girona, Girona, Spain.; Sedano A; Human Resources Department, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Plans À; Occupational Health Unit, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Calvo-Cerrada B; Occupational Health Unit, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Calle C; General Direction, Institut Català d'Oncologia (ICO), L'Hospìtalet de Llobregat, Spain.; Clopés A; Scientific Direction, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Carnicer-Pont D; Epidemiology and Public Health Programme, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.; Cancer Prevention and Control Programme, Cancer Epidemiology and Prevention Department, Institut català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; CIBER of Respiratory Diseases (CIBERES), Madrid, Spain.; WHO Collaborating Center for Tobacco Control, Institut català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Alemany L; Cancer Epidemiology Research Programme, Cancer Epidemiology and Prevention Department, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; Epidemiology and Public Health Programme, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.; CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Fernández E; Epidemiology and Public Health Programme, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain efernandez@iconcologia.net.; School of Medicine and Clinical Sciences, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.; Cancer Prevention and Control Programme, Cancer Epidemiology and Prevention Department, Institut català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.; CIBER of Respiratory Diseases (CIBERES), Madrid, Spain.; WHO Collaborating Center for Tobacco Control, Institut català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Ramírez-Tarruella, D.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어